The KIT spin-off GoSilico develops software for computer-assisted process development in the biopharmaceutical industry. Its simulation technology helps companies display experiments on their computers within seconds. We have interviewed the GoSilico GmbH team on their idea, the foundation of their company and their future perspective.
pharmaceutical
Award winning cancer research – KIT spin-off amcure GmbH convinces at the CyberOne Award with a new approach for the pancreatic cancer therapy

The amcure GmbH in Karlsruhe was awarded with the second place of the Cyber One Award on June 12th, 2012 for its new active substance against pancreatic cancer. Furthermore, the amcure GmbH was awarded the renowned special prize of the state of Baden-Württemberg. The four company founders of the young spin-off of the Karlsruhe Institute of Technology work on the active substance AM001, which could open up new possibilities of treating cancer of the pancreas in the future.